FIELD: medicine.
SUBSTANCE: blood plasma is process in a medium containing 10% polyvinylpyrrolidone. Blood atherogenicity is stated visually if observing opacity of an examined sample. The use of the method allows carrying out screening in a relatively short time and detecting people with propensity for atherosclerosis. In-depth study of such patients shall allow detecting an individual reason of blood atherogenicity and performing etiotropic therapy at the pre-clinical stages of atherosclerosis.
EFFECT: reduced time of screening, possibility to detect people with propensity for atherosclerosis.
7 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDIUM AND METHOD FOR DETECTION OF MULTIPLY MODIFIED BLOOD SERUM LIPOPROTEINS | 2010 |
|
RU2444014C1 |
| METHOD TO DETERMINE ATHEROGENICITY OF HUMAN BLOOD | 2012 |
|
RU2497116C1 |
| METHOD FOR DETERMINING MINIMUM MODIFIED LIPOPROTEINS OF LOW DENSITY IN SERUM OR PLASMA OF HUMAN BLOOD | 2012 |
|
RU2501013C1 |
| METHOD FOR RAPID DETERMINATION OF CHOLESTEROL IN IMMUNE COMPLEXES | 2012 |
|
RU2530627C2 |
| METHOD FOR SELECTION AND STUDY OF ATHEROGENICITY OF IMMUNE COMPLEXES CONTAINING MULTIPLE MODIFIED LIPOPROTEINS | 2016 |
|
RU2632118C1 |
| METHOD AND TEST SYSTEM FOR DETECTION OF CIRCULATING IMMUNE COMPLEXES | 2010 |
|
RU2452962C2 |
| METHOD FOR SEPARATION AND QUANTITATIVE DETERMINATION OF MULTIPLY MODIFIED LOW-DENSITY LIPOPROTEINS | 2015 |
|
RU2592238C1 |
| METHOD FOR DETERMINING LYSIS MULTIPLE MODIFIED LOW DENSITY LIPOPROTEIN | 2015 |
|
RU2577719C1 |
| METHOD FOR RAPID DETERMINATION OF RESISTANCE TO LDL OXIDATION OF HUMAN SERUM | 2015 |
|
RU2578027C1 |
| METHOD FOR RAPID ANALYSIS OF CHOLESTEROL IN IMMUNE COMPLEXES | 2013 |
|
RU2538685C1 |
